BRIEF-ALK Abelló: Marketing authorisation for Acarizax issued in France Jan 27 Alk Abello A/S :* Says that authorities in France have issued a marketing authorisation for ALK's new house dust mite sublingual allergy immuno-therapy tablet (slit-tablet), Acarizax Source text for Eikon: Further company coverage: (Gdynia Newsroom)
CANADA STOCKS-TSX rises to 5-month high, rebounds 20 pct from Jan trough
S.Korea's NOFI buys corn and wheat via tenders
Kenya says its forces kill 34 al Shabaab fighters in Somalia